WO2008001201A3 - Pharmaceutical compositions of clopidogrel - Google Patents

Pharmaceutical compositions of clopidogrel Download PDF

Info

Publication number
WO2008001201A3
WO2008001201A3 PCT/IB2007/001753 IB2007001753W WO2008001201A3 WO 2008001201 A3 WO2008001201 A3 WO 2008001201A3 IB 2007001753 W IB2007001753 W IB 2007001753W WO 2008001201 A3 WO2008001201 A3 WO 2008001201A3
Authority
WO
WIPO (PCT)
Prior art keywords
clopidogrel
pharmaceutical compositions
relates
compositions
processes
Prior art date
Application number
PCT/IB2007/001753
Other languages
French (fr)
Other versions
WO2008001201A2 (en
Inventor
Narayanan Murali
Anandkrishna Laxmikan Kulkarni
Abdul Rehman Khan
Girish Kumar Jain
Amol Prasadrao Ujjainkar
Original Assignee
Wockhardt Ltd
Narayanan Murali
Anandkrishna Laxmikan Kulkarni
Abdul Rehman Khan
Girish Kumar Jain
Amol Prasadrao Ujjainkar
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Wockhardt Ltd, Narayanan Murali, Anandkrishna Laxmikan Kulkarni, Abdul Rehman Khan, Girish Kumar Jain, Amol Prasadrao Ujjainkar filed Critical Wockhardt Ltd
Publication of WO2008001201A2 publication Critical patent/WO2008001201A2/en
Publication of WO2008001201A3 publication Critical patent/WO2008001201A3/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/47—Quinolines; Isoquinolines
    • A61K31/4738—Quinolines; Isoquinolines ortho- or peri-condensed with heterocyclic ring systems
    • A61K31/4743—Quinolines; Isoquinolines ortho- or peri-condensed with heterocyclic ring systems condensed with ring systems having sulfur as a ring hetero atom
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2013—Organic compounds, e.g. phospholipids, fats
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2013—Organic compounds, e.g. phospholipids, fats
    • A61K9/2018—Sugars, or sugar alcohols, e.g. lactose, mannitol; Derivatives thereof, e.g. polysorbates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2022—Organic macromolecular compounds
    • A61K9/2027—Organic macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyvinyl pyrrolidone, poly(meth)acrylates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2022—Organic macromolecular compounds
    • A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
    • A61K9/2054—Cellulose; Cellulose derivatives, e.g. hydroxypropyl methylcellulose
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1605—Excipients; Inactive ingredients
    • A61K9/1617—Organic compounds, e.g. phospholipids, fats
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1605—Excipients; Inactive ingredients
    • A61K9/1629—Organic macromolecular compounds
    • A61K9/1641—Organic macromolecular compounds obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyethylene glycol, poloxamers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1605—Excipients; Inactive ingredients
    • A61K9/1629—Organic macromolecular compounds
    • A61K9/1652—Polysaccharides, e.g. alginate, cellulose derivatives; Cyclodextrin

Abstract

The present invention relates to pharmaceutical compositions of clopidogrel or pharmaceutically acceptable salts thereof. The invention also relates to processes for the preparation of such compositions.
PCT/IB2007/001753 2006-06-28 2007-06-27 Pharmaceutical compositions of clopidogrel WO2008001201A2 (en)

Applications Claiming Priority (8)

Application Number Priority Date Filing Date Title
IN1021/MUM/2006 2006-06-28
IN1016MU2006 2006-06-28
IN1016/MUM/2006 2006-06-28
IN1021MU2006 2006-06-28
IN1974MU2006 2006-12-01
IN1974/MUM/2006 2006-12-01
IN1973MU2006 2006-12-01
IN1973/MUM/2006 2006-12-01

Publications (2)

Publication Number Publication Date
WO2008001201A2 WO2008001201A2 (en) 2008-01-03
WO2008001201A3 true WO2008001201A3 (en) 2009-04-23

Family

ID=38846027

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/IB2007/001753 WO2008001201A2 (en) 2006-06-28 2007-06-27 Pharmaceutical compositions of clopidogrel

Country Status (1)

Country Link
WO (1) WO2008001201A2 (en)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ES2408380T3 (en) * 2007-04-20 2013-06-20 Wockhardt Limited Clopidogrel pharmaceutical compositions
CN102240269B (en) * 2010-05-12 2013-04-10 天津泰普药品科技发展有限公司 Preparation method of crystalline clopidogrel bisulfate tablets
CN103417502B (en) * 2013-08-05 2015-09-23 青岛市中心医院 A kind of clopidogrel hydrogen sulfate tablet and preparation method thereof
CN105380916A (en) * 2015-12-18 2016-03-09 北京华禧联合科技发展有限公司 Tablets containing clopidogrel hydrogen sulfate and preparation method thereof
WO2017204582A1 (en) * 2016-05-27 2017-11-30 Hanmi Pharm. Co., Ltd. Pharmaceutical composition comprising an amide derivative or a pharmaceutically acceptable salt thereof inhibiting growth of cancer cells and a stabilizer having low melting point
CN108186604A (en) * 2018-03-28 2018-06-22 北京睿悦生物医药科技有限公司 A kind of bisulfate clopidogrel particle and preparation method thereof
CN110339178B (en) * 2019-06-28 2021-07-02 广州白云山天心制药股份有限公司 Preparation method of clopidogrel hydrogen sulfate solid preparation
CN113057944B (en) * 2019-12-13 2022-09-16 华益泰康药业股份有限公司 Preparation method of tablets with improved performance
CN114732788A (en) * 2022-04-14 2022-07-12 浙江高跖医药科技股份有限公司 Clopidogrel hydrogen sulfate solid preparation and preparation process thereof
CN115737578A (en) * 2022-11-23 2023-03-07 石家庄四药有限公司 Clopidogrel hydrogen sulfate and aspirin compound tablet and preparation method thereof

Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20050030004A1 (en) * 2001-11-26 2005-02-10 Toshinori Takatsuka Current sensor
US20050152975A1 (en) * 1999-03-17 2005-07-14 Daiichi Pharmaceutical Co., Ltd. Pharmaceutical composition

Patent Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20050152975A1 (en) * 1999-03-17 2005-07-14 Daiichi Pharmaceutical Co., Ltd. Pharmaceutical composition
US20050030004A1 (en) * 2001-11-26 2005-02-10 Toshinori Takatsuka Current sensor

Also Published As

Publication number Publication date
WO2008001201A2 (en) 2008-01-03

Similar Documents

Publication Publication Date Title
WO2008001201A3 (en) Pharmaceutical compositions of clopidogrel
WO2010092090A3 (en) Novel salts of sitagliptin
WO2008013838A3 (en) Pyridizinone derivatives
WO2009066326A3 (en) Improved process for the preparation of prasugrel and its pharmaceutically acceptable salts
WO2008005565A3 (en) Antiviral phosphinate compounds
ZA200900347B (en) Preparation of pharmaceutical compositions
EP2076244A4 (en) Aqueous systems for the preparation of lipid-based pharmaceutical compounds; compositions, methods, and uses thereof
WO2008129501A3 (en) Pharmaceutical compositions of duloxetine
WO2012021715A3 (en) Stable formulations of linaclotide
WO2011157721A3 (en) Ivabradine-containing pharmaceutical composition
WO2008072053A8 (en) Substituted arylpyrazoles
WO2010049449A3 (en) Novel salts of sunitinib
IL194961A0 (en) Compounds a-r-x for the manufacture of pharmaceutical preparations
WO2012070062A3 (en) Novel polymorph of nilotinib hydrochloride
WO2008083130A3 (en) Amorphous and crystalline form a of carvedilol phosphate
WO2010070677A3 (en) A process for the preparation of prasugrel and its pharmaceutically acceptable salts thereof
WO2008088779A3 (en) Solid state forms of 5-azacytidine and processes for preparation thereof
WO2008051564A3 (en) Crystalline forms of palonosetron hydrochloride
WO2008081268A3 (en) Pharmaceutical compositions of entacapone
WO2010006904A3 (en) Crystalline forms of rabeprazole sodium
WO2008137134A3 (en) Amorphous eletriptan hydrobromide and process for preparing it and other forms of eletriptan hydrobromide
WO2009140105A3 (en) Formulations for cathepsin k inhibitors
WO2007125521A3 (en) Polymorphic form of zoledronic acid and processes for their preparation
TN2012000105A1 (en) Spirolactam derivatives and uses of same
WO2008034912A3 (en) Process for the synthesis of clopidogrel and new forms of pharmaceutically acceptable salts thereof

Legal Events

Date Code Title Description
121 Ep: the epo has been informed by wipo that ep was designated in this application

Ref document number: 07789454

Country of ref document: EP

Kind code of ref document: A2

NENP Non-entry into the national phase

Ref country code: DE

NENP Non-entry into the national phase

Ref country code: RU

122 Ep: pct application non-entry in european phase

Ref document number: 07789454

Country of ref document: EP

Kind code of ref document: A2